IFF · Industrials

INTERNATIONAL FLAVORS & FRAGRANCES INC

Ranked earnings events from SEC filings, earnings calls, press releases and news. Full Picture: what to focus on this earnings window

News · 2026-08-08

• Capital Return ProgramImportance 64 · Surprise 42
  IFF authorized an enhanced $2.5 billion share-repurchase program while maintaining its quarterly dividend at $0.40 per share. Management linked the capital-allocation plan to the pending Food Ingredients divestiture…
• Liquidity and Debt PositionImportance 64 · Surprise 42
  IFF plans to use proceeds from the Food Ingredients divestiture to reduce debt by more than $1 billion. The company’s $2.5 billion repurchase authorization increases the importance of cash generation and balance-sheet…

News · 2026-08-07

• Liquidity and Debt PositionImportance 64 · Surprise 42
  IFF plans to use proceeds from the Food Ingredients divestiture to reduce debt by more than $1 billion. The company’s $2.5 billion repurchase authorization increases the importance of cash generation and balance-sheet…

News · 2026-08-06

• Revenue Performance and MixImportance 31 · Surprise 32
  IFF reported second-quarter 2026 revenue of $1.95 billion, up 1.8% year over year on a continuing-operations basis from approximately $1.92 billion. Organic revenue increased 6% year over year, supported by volume…

News · 2026-08-05

• Guidance / OutlookImportance 90 · Surprise 84
  IFF reduced its full-year 2026 revenue outlook to a range of $7.4 billion to $7.6 billion, with one report citing a midpoint of approximately $7.5 billion. The revised range is materially below the $10.4 billion…
• Capital Return ProgramImportance 64 · Surprise 42
  IFF authorized an enhanced $2.5 billion share-repurchase program while maintaining its quarterly dividend at $0.40 per share. Management linked the capital-allocation plan to the pending Food Ingredients divestiture…
• Liquidity and Debt PositionImportance 64 · Surprise 42
  IFF plans to use proceeds from the Food Ingredients divestiture to reduce debt by more than $1 billion. The company’s $2.5 billion repurchase authorization increases the importance of cash generation and balance-sheet…
• Acquisition / Partnership / DivestitureImportance 58 · Surprise 42
  IFF is divesting its Food Ingredients business to CVC Capital Partners as part of a portfolio shift toward Taste, Scent, and Health & Biosciences. IFF will retain a 10% minority stake in the divested business,…
• Margin DriversImportance 58 · Surprise 42
  IFF attributed second-quarter performance to productivity gains and volume growth across all segments. Management expects input-cost inflation to pressure margins in the second half of 2026. The company also identified…
• Market Demand TrendsImportance 43 · Surprise 32
  IFF reported approximately 6% sales growth in the second quarter on a continuing-operations basis, with volume growth across its Taste, Health & Biosciences, and Scent segments. The reported growth indicates improving…
• Revenue Performance and MixImportance 31 · Surprise 32
  IFF reported second-quarter 2026 revenue of $1.95 billion, up 1.8% year over year on a continuing-operations basis from approximately $1.92 billion. Organic revenue increased 6% year over year, supported by volume…

10-Q · 2026-08-04

• Capital Expenditures and ReturnsImportance 73 · Surprise 50
  IFF spent $301 million on property, plant, and equipment during the first six months of 2026 and expects full-year 2026 capital spending to equal approximately 6.0% of total company sales, up from 5.5% in 2025. The…
• Regulatory RiskImportance 72 · Surprise 74
  Selling and administrative expenses included higher regulatory costs, contributing to a $28 million increase in second-quarter S&A expense to $437 million. Regulatory costs totaled $71 million in second-quarter 2026…
• Acquisitions and DivestituresImportance 71 · Surprise 60
  IFF entered into a definitive agreement on May 29, 2026 to divest its Food Ingredients disposal group, which was classified as held for sale and discontinued operations in the second quarter. The Food Ingredients group…
• Portfolio Reshaping (M&A / Divestiture)Importance 71 · Surprise 60
  On May 29, 2026, IFF entered into a definitive agreement to divest its Food Ingredients disposal group and classified that group, together with the SCL disposal group, as discontinued operations during the second…
• Operating Cash Flow TrendsImportance 69 · Surprise 64
  Operating cash flow increased $311 million to $679 million in the first six months of 2026 from $368 million in 2025. The improvement was primarily driven by lower working capital, including inventory and accounts…
• Capital Expenditure OutlookImportance 67 · Surprise 50
  IFF spent $301 million on property, plant and equipment during the first six months of 2026. Management re-prioritized capital projects and expects 2026 capital spending to equal approximately 6.0% of total company…
• Capital Return ProgramImportance 64 · Surprise 42
  On August 4, 2026, IFF's Board authorized an enhanced share-repurchase program with a total value of $2.5 billion, including approximately $400 million remaining under the prior authorization. The Board also authorized…
• Supply Chain Tariff ImpactImportance 52 · Surprise 42
  IFF recognized tariff refunds as a benefit to gross profit and cost of sales in the second quarter and first six months of 2026. The refunds contributed to the $29 million year-over-year increase in second-quarter…
• Revenue Performance and MixImportance 49 · Surprise 32
  Second-quarter 2026 continuing-operations sales increased $35 million, or 2% reported, to $1.954 billion, while comparable currency-neutral sales increased 6% year over year. Taste sales rose 5% to $688 million, Health…
• Gross Margin DriversImportance 49 · Surprise 32
  Second-quarter gross profit increased $29 million, or 4%, to $853 million, and gross margin expanded 80 basis points to 43.7% from 42.9%. Six-month gross profit increased to $1.682 billion from $1.676 billion, while…
• Liquidity and Debt PositionImportance 49 · Surprise 6
  Cash and cash equivalents totaled $569 million at June 30, 2026, down from $590 million at December 31, 2025. Total debt was $5.735 billion and net debt was $5.166 billion, producing a…
• End-Market Demand TrendsImportance 49 · Surprise 32
  Second-quarter Taste sales rose 4% on a comparable currency-neutral basis, driven primarily by volume and price increases in Flavors serving savory foods, beverages, sweets, dairy, food service and alternative-protein…
• Headcount / RestructuringImportance 45 · Surprise 64
  Second-quarter restructuring and other charges declined to $6 million from $20 million in the prior-year quarter. Six-month restructuring charges declined to $10 million from $35 million. The reduction primarily…
• Operating Expense TrendsImportance 42 · Surprise 14
  Second-quarter R&D expense was unchanged at $170 million, representing 8.7% of sales versus 8.9% in 2025. Second-quarter S&A expense increased $28 million to $437 million, or 22.4% of sales, primarily because of higher…
• Income Tax Rate ChangesImportance 42 · Surprise 64
  The second-quarter effective tax rate increased to 48.4% from negative 25.6% in the prior-year quarter. The six-month effective tax rate increased to 27.7% from negative 17.5%. The changes were driven by increased…
• FX / Currency HeadwindsImportance 31 · Surprise 32
  Exchange-rate movements provided a favorable $35 million, or 2%, impact on second-quarter sales and a 3% favorable impact on first-six-month sales. Currency effects varied by business and region based on the mix of…

8-K · 2026-08-04

• Acquisition / Partnership / DivestitureImportance 71 · Surprise 60
  IFF’s recast periods exclude the Food Ingredients and Soy Crush, Concentrates and Lecithin disposal groups from continuing operations. The company completed the sale of the Pharma Solutions disposal group, which…
• Operating Income and MarginsImportance 64 · Surprise 56
  First-quarter 2026 operating profit increased 42.1% year over year to $253 million from $178 million. Operating margin expanded to 13.3% from 8.7%, a 460-basis-point improvement on the $1,906 million revenue base.…
• Headcount / RestructuringImportance 59 · Surprise 82
  Restructuring and other charges were $4 million in the first quarter of 2026, down from $15 million in the first quarter of 2025. The charges primarily related to the IFF Productivity Program, including severance,…
• Regulatory RiskImportance 58 · Surprise 42
  IFF incurred $106 million of regulatory costs in 2025, primarily for legal fees and provisions related to ongoing investigations of its fragrance businesses. Regulatory costs were $10 million in the first quarter of…
• Gross Margin DriversImportance 54 · Surprise 40
  Consolidated gross profit was $829 million in the first quarter of 2026 versus $852 million in the first quarter of 2025, while gross margin increased to 43.5% from 41.6% because sales declined less than cost of sales.…
• Operating Expense TrendsImportance 54 · Surprise 40
  Research and development expense was $154 million in the first quarter of 2026, down 0.6% from $155 million in the first quarter of 2025 and equal to approximately 8.1% of sales. Selling and administrative expense…
• Portfolio Reshaping (M&A / Divestiture)Importance 52 · Surprise 42
  IFF reported $125 million of divestiture and integration costs in 2025, including $98 million on a recast continuing-operations basis. First-quarter 2026 divestiture and integration costs were $24 million as reported…
• Revenue Performance and MixImportance 49 · Surprise 32
  First-quarter 2026 net sales were $1,906 million, down 7.0% from $2,050 million in the first quarter of 2025 but up 6.4% from $1,792 million in the fourth quarter of 2025. On a recast continuing-operations basis, Taste…

8-K · 2026-08-04

• Financial GuidanceImportance 80 · Surprise 68
  IFF introduced full-year 2026 continuing-operations guidance of $7.4 billion to $7.6 billion in sales and $1.53 billion to $1.60 billion in adjusted operating EBITDA, excluding approximately $3.2 billion and $520…
• Acquisitions and DivestituresImportance 77 · Surprise 82
  The comparable presentation excludes the Rene Laurent business following its divestiture on December 1, 2025. It also excludes the Pharma Solutions disposal group and Nitrocellulose business following divestitures…
• Food Ingredients DivestitureImportance 71 · Surprise 60
  IFF agreed on May 29, 2026 to sell its Food Ingredients disposal group to CVC Capital Partners for approximately $3.8 billion of net cash proceeds, subject to customary adjustments and regulatory approvals. The…
• Capital Allocation and RepurchasesImportance 71 · Surprise 60
  IFF plans to use more than $1 billion of net Food Ingredients divestiture proceeds to reduce outstanding debt while maintaining a target net-debt-to-EBITDA leverage range of 2.0x to 2.5x. The Board authorized a $2.5…
• Operating Cash Flow and CapexImportance 69 · Surprise 64
  Cash flow from operations for the first six months of 2026 was $679 million, up $311 million year over year from $368 million. Free cash flow was $378 million, up $284 million year over year. Capital expenditures were…
• Regulatory RiskImportance 69 · Surprise 74
  IFF reported $71 million of regulatory costs in second-quarter 2026, compared with $53 million in the prior-year period. For the first six months of 2026, regulatory costs totaled $81 million, compared with $64 million…
• Headcount and RestructuringImportance 59 · Surprise 82
  Second-quarter restructuring and other charges were $6 million, down 70% from $20 million, and first-half charges were $10 million, down 71% from $35 million. The charges primarily represent severance under the IFF…
• Stranded Cost ReductionImportance 58 · Surprise 42
  The Food Ingredients transaction is expected to leave approximately $100 million of annual corporate and functional stranded costs with IFF after closing. IFF expects to eliminate approximately two-thirds of those…
• Liquidity and Debt PositionImportance 56 · Surprise 24
  At June 30, 2026, IFF had $569 million of cash and $5.735 billion of total debt, comprising $964 million of short-term borrowings and $4.735 billion of long-term debt. Net debt was $5.166 billion, and net debt to…
• Income Tax Rate ChangesImportance 51 · Surprise 64
  Second-quarter continuing-operations income tax expense was $31 million on $64 million of pretax income, compared with a $112 million tax benefit on $438 million of pretax income in the prior-year period. First-half…
• Market Demand TrendsImportance 43 · Surprise 32
  IFF reported broad-based second-quarter demand growth across its continuing operations, with comparable currency-neutral sales up 6%. Taste sales increased 4%, led by volume growth across all regions, while Health &…
• Revenue Performance and MixImportance 42 · Surprise 14
  Second-quarter 2026 reported net sales were $1.954 billion, up 2% year over year, while comparable currency-neutral sales increased 6%. Taste generated $688 million of sales, Health & Biosciences generated $601…
• Segment ProfitabilityImportance 42 · Surprise 14
  Second-quarter 2026 currency-neutral adjusted operating EBITDA increased 6% for the consolidated company, with segment growth of 6% in Taste, 6% in Health & Biosciences, and 5% in Scent. Reported segment adjusted…
• Operating Expense TrendsImportance 42 · Surprise 14
  Second-quarter research and development expense was $170 million, unchanged from the prior-year period. Selling and administrative expense increased 7% year over year to $437 million, while adjusted selling and…
• FX / Currency HeadwindsImportance 30 · Surprise 24
  Currency translation reduced second-quarter 2026 reported sales by 2% for Taste, 3% for Health & Biosciences, 2% for Scent, and 2% on a consolidated basis. Currency reduced second-quarter adjusted operating EBITDA by…
• Middle East Conflict ImpactImportance 30 · Surprise 50
  IFF said Fine Fragrance growth was affected by the Middle East conflict during the second quarter of 2026. The Fine Fragrance business increased only low-single digits versus the prior-year period, while the broader…
• Geographic Market CommentaryImportance 17 · Surprise 24
  Taste achieved comparable currency-neutral sales growth across all regions, indicating broad geographic demand strength. The release does not quantify individual regional growth rates, but describes Taste performance…
• Pricing and PromotionsImportance 15 · Surprise 14
  Taste’s second-quarter adjusted operating EBITDA increased 6% on a comparable currency-neutral basis. Management attributed the improvement primarily to volume growth and favorable net pricing, indicating that pricing…

News · 2026-08-04

• Guidance / OutlookImportance 90 · Surprise 84
  IFF reduced its full-year 2026 revenue outlook to a range of $7.4 billion to $7.6 billion, with one report citing a midpoint of approximately $7.5 billion. The revised range is materially below the $10.4 billion…
• Capital Return ProgramImportance 64 · Surprise 42
  IFF authorized an enhanced $2.5 billion share-repurchase program while maintaining its quarterly dividend at $0.40 per share. Management linked the capital-allocation plan to the pending Food Ingredients divestiture…
• Market Demand TrendsImportance 43 · Surprise 32
  IFF reported approximately 6% sales growth in the second quarter on a continuing-operations basis, with volume growth across its Taste, Health & Biosciences, and Scent segments. The reported growth indicates improving…
• Revenue Performance and MixImportance 31 · Surprise 32
  IFF reported second-quarter 2026 revenue of $1.95 billion, up 1.8% year over year on a continuing-operations basis from approximately $1.92 billion. Organic revenue increased 6% year over year, supported by volume…